In3ator

The disparity in newborn survival rates across geographic regions, particularly in Sub-Saharan Africa and southern and central Asia, underscores significant global health challenges. Sub-Saharan Africa recorded the highest neonatal mortality rate worldwide in 2022, with 27 deaths per 1000 live births, an 11-fold increase compared to regions like Australia and New Zealand. Analysis by the Integrated African Health Observatory (IAHO) reveals that 12.5% of these deaths occur within the neonatal period, while 14.5% occur between ages 1 and 59 months.

The diversity of this region requires cost-effective digital health interventions that consider varying socio-economic, geographic, and cultural contexts to improve health outcomes. Cameroon and Ethiopia, with their distinct healthcare challenges, have made strides in improving infant and neonatal health yet still face significant hurdles. According to the WHO, Ethiopia reported a neonatal mortality rate of 29 deaths per 1000 live births in 2019, while Cameroon's rate stood at 33, indicating a pressing need for targeted interventions. 

In Ethiopia, with an annual birth rate of approximately 2.5 million births, and in Cameroon, with about 0.6 million births, even a modest 1% reduction in neonatal mortality could save thousands of lives annually and could potentially prevent approximately 250 neonatal deaths in Ethiopia and 60 in Cameroon in specific sites each year. Beyond immediate mortality reduction, such interventions promise improved long-term health outcomes, diminished childhood infectious diseases and disabilities, and alleviated economic strains on families and governments. 

Preterm birth complications, respiratory distress syndrome, sepsis, pneumonia, meningitis, asphyxia, hypothermia, and various infections are identified as the primary causes of mortality and morbidity among newborns and infants in typical Sub-Saharan African countries like Ethiopia and Cameroon. These conditions are closely associated with prevalent infectious diseases including HIV, malaria, diarrheal diseases, and lower respiratory tract infections, significantly influencing the life expectancy and quality of life of neonates and infants within these populations. Such sources of morbidity could be prevented with the use of neonatal resuscitation devices and incubators. Neonatal resuscitation prevents morbidity and mortality associated with hypoxic-ischaemic tissue injury (affecting the brain, heart and kidneys) and re-establishes spontaneous respiration and cardiac output. The average resuscitation device in the EU, providing a more controlled and constant peak inspiratory pressure (PIP) and positive end-expiratory pressure (PEEP), costs €5000. Incubators, which facilitate isolation while maintaining specialised levels of light, temperature, humidity, and oxygen optimised for the baby's development, cost €12,000. 

Moreover, these health challenges are exacerbated by a myriad of factors such as birth order, access to antenatal care, location of delivery, gestational age, occurrence of multiple births, premature rupture of membranes, labor complications, neonatal care practices, limited healthcare accessibility, and inadequate infrastructure. Access to fundamental lifesaving interventions, including the provision of skilled midwifery during childbirth, high-quality postnatal care, promotion of breastfeeding, provision of adequate nutrition, vaccination initiatives, and access to treatment for common childhood illnesses, holds the potential to significantly mitigate neonatal and infant mortality rates within these regions, ultimately preserving the lives of many young individuals.

The core technological solution, In3ator, is strategically embedded and intertwined with Open Medical World's ACUNA2 Program, which outlines the organization's middle to long-term plan of action. ACUNA2 is further outlined in subsequent sections. 

The creation of the In3ator, itself, achieves objective 1: The development of the initial set of digital healthcare devices. The In3ator will focus on addressing the defined medical challenges and the socio-technical and infrastructural constraints of the regions of operation. Integrating monitoring options based on specific KPIs will allow us to evaluate the effectiveness, usability, and sustainability of these technologies in real-world settings. 

The In3ator is an emergency climatic cradle capable of providing a neutral and humid thermal environment for the newborn. It is a plastic structure (PE-300, PETG, PLA) with transparent dome and side access ports with stainless steel screws. The In3ator can be disassembled to fit in a 23kg suitcase. Cost of materials hovers around 350€ - 380€.

Additionally, In3ator has a modular design. This means that each developed feature is independent of the others. This allows the incubator to be customised to the maximum, thus adapting it to the specific needs of the user.

The In3ator is a continously evolving product, where each new version is designed to become more efficient, stable, convenient, and powerful than the previous. At the same time, it always aims to ensure the minimum amount of materials required as to avoid complications in production and assembly and keep cost as low as possible. 

As of the most recent In3ator version 9.C published in 2022, the In3ator has the following medical capabilities: 

• Temperature regulation (air and skin).
  • Air: the device adjusts the temperature of the cubicle air. Able to increase the air temperature up to +15ºC.
  • Skin: the device adjusts the temperature of the baby's skin by contact with the sensor in the armpit. 
• Humidity control. Ability to increase the relative humidity of the air up to 90%.
• Phototherapy (neonatal jaundice treatment).
• Bed inclination (8% to avoid reflux).
• Forced air ventilation.

Tecnical capabilities include: 

• 2.8 inch colour screen
• Audible and visual alarm: Default alarms required in IEC 60601-2-19 standards by the International Electrotechnical Comission specifying safety requirements for INFANT INCUBATORS.
• 2G and WIFI connectivity
• 220/110 AC or 12V DC operation.
• Water-repellent anti-decubitus mattress
• Peak power: 130W
• Weight: 12.5 Kg
• Detachable to fit in a 23Kg check-in suitcase

This project focuses on neonates, small infants, and caregivers to improve health and well-being of children around the world. 

Healthcare professionals who will receive advanced training and AI-based decision-support tools, empowering professionals in resource-limited regions; and policymakers and health managers where the project will inform and improve local, regional, and national health policies and clinical practices, promoting resilient and patient-centered health systems, and the generation of robust evidence and the demonstration of the cost-effectiveness and sustainability of innovative solutions. 

The In3ator team is a multidisciplinary group with diverse expertise. At the forefront are pediatricians who not only recognized the high mortality rates in developing countries but also identified the critical factors to save neonates. Additionally, our team includes engineers from various fields such as industrial, biomedical, electronics, and telecommunications, each contributing unique insights to our work.

Globally, there are hundreds of In3ators in operation, and the feedback has been overwhelmingly positive. The In3ator initiative is part of a Medical Open World project with established donors and revenue streams, ensuring financial sustainability. The cost-effective design of In3ator means that 95% of our units are affordable for hospitals and NGOs. Revenue from donors is reinvested into research and development, and it also helps cover the cost of units for end users who might otherwise find them out of reach.

In3ator's goal is to be more than just a life-saving device; it's also intended to foster a strong connection between the community and the development team. Thanks to its internet connection, we actively seek and value input from users, which helps us improve the In3ator to be more effective, user-friendly, and durable.

We classify our project, In3ator, in the "Growth" stage, acknowledging that while we have made significant advancements, we are not yet in the phase of scaling up. In3ator is an established innovation currently in operation across multiple communities, including those in Sub-Saharan Africa, Senegal, and Ukraine. The design and technological approach of In3ator have been standardized, making it ready for expansion into more regions globally, that bolsters moderately frequent updates to the design being made over time, with version 10 to be made public shortly. Our focus remains on enhancing the design and efficacy of In3ator and achieving certification that validates its effectiveness before considering broader expansion. Furthermore, this stage reflects our established presence in several communities and our ongoing efforts to refine and improve upon the existing technology to meet diverse healthcare needs more effectively.

Our current financial sustainability largely depends on donations and grant funding, which underpins the production and deployment of the In3ators. This funding model has enabled us to launch over 150 units worldwide, particularly in under-resourced settings where such life-saving equipment is most needed. However, recognizing the limitations of relying predominantly on donations and grants, we are exploring new avenues for revenue generation. Ideas include initiating programs like In3ator sponsorship or adoption by the general public, which would allow individuals or corporations to directly support the deployment of units in specific regions or facilities. This approach not only aims to diversify our revenue streams but also to engage a broader audience in our mission, increasing community involvement and investment in our work. 

As we move forward, securing official certification for In3ator will be crucial. This certification will not only enhance our credibility but also improve our ability to attract additional funding and support, setting a solid foundation for eventual scaling when the time is right. Alongside this, our current objective remains to establish local laboratories for the production of In3ators directly in the regions we serve first, before truly scaling up. By developing these manufacturing hubs, we aim to enhance our impact in areas where our presence is already established. This strategy not only reduces the logistical costs associated with shipping but also empowers local communities. We are exploring innovative approaches, such as integrating In3ator manufacturing into engineering curricula, similar to successful models in some Northern European countries. Such initiatives provide dual benefits: they reduce production costs and foster local expertise, enabling communities to address and fulfill their specific healthcare needs more effectively.

Our initiative, In3ator, which delivers critical neonatal care through a portable and innovative incubator system, faces several substantial barriers that we believe Solve can help us address:

1. Technical Challenges: Although In3ator is functionally effective, continuous improvement in its design and features is necessary to keep pace with technological advances and healthcare needs. We hope to gain insights from Solve’s technology experts and partner organizations who can provide mentorship in refining our product, enhancing its scalability, and integrating cutting-edge technologies that can lead to broader deployment in various environments.

2. Market Access and Expansion: We aim to expand our reach to more regions, especially in developing countries where such medical devices are desperately needed yet difficult to introduce due to regulatory and logistical complexities. Solve's network of global partners could facilitate entry into these markets through strategic partnerships and guidance on navigating local regulations and market dynamics.

3. Legal and Regulatory Guidance: Certifying medical devices and meeting international standards can be a significant hurdle. Access to Solve’s legal experts could assist us in understanding and complying with international health regulations and securing necessary approvals, thus speeding up the process of bringing our device to new markets.

4. Sustainability and Financial Strategy: While our current model relies heavily on donations and grants, we need to explore sustainable financial models that can ensure long-term viability without compromising our mission to provide affordable care. We believe Solve’s ecosystem of impact investors and business mentors can help us devise innovative funding strategies, potentially including social impact bonds, microfinancing solutions, or a pay-as-you-save scheme.

5. Cultural Engagement: Successfully introducing new technologies in healthcare requires sensitivity to local cultural practices and beliefs. Solve’s global community can offer valuable insights into cultural nuances and help us tailor our deployment strategies to be more culturally respectful and effective.

At the heart of our In3ator innovation is internet connectivity, which offers a new level of monitoring and support for our devices worldwide. This connectivity allows us to keep track of each device's performance, providing health professionals with real-time insights into their operation.

Through this feature, our team can collaborate with healthcare staff around the world in real time, helping them address any issues as they arise. This immediate communication ensures that any technical challenges are swiftly resolved, reducing downtime and keeping critical medical equipment operational when it’s needed most.

In3ator features internal sensors that continuously monitor each component's functionality, alerting the maintenance team if something is amiss. With this early detection, we can guide the repair process efficiently, reducing the time and resources typically required for troubleshooting.

Additionally, the in3ator's intelligent system helps to extend the device's lifespan. By identifying and addressing issues quickly, we can prevent small problems from escalating into major repairs. This proactive approach not only ensures reliable performance but also contributes to long-term durability.

Our theory of change is built around the idea that connecting communities to technology and expertise can improve healthcare outcomes, particularly in low-income areas with limited resources. We expect our solution, In3ator, to have a significant impact by providing life-saving medical equipment and fostering knowledge exchange. Here's a breakdown of how and why we believe our solution will work and lead to social impact:

1. Identifying the Problem

In many developing regions, neonatal care is hampered by a lack of reliable medical equipment and trained personnel. Traditional incubators are expensive and require ongoing maintenance, which many low-income facilities cannot afford. This leads to inadequate care for newborns and, consequently, higher infant mortality rates.

2. Providing Cost-Effective Solutions

Our In3ator is designed to address this problem by offering an affordable, easy-to-use, and maintainable solution. By partnering with Salesian schools, we can manufacture the incubators at a lower cost, enabling wider distribution to areas in need. This approach also allows for localized production, reducing logistics costs and ensuring quicker delivery to healthcare facilities.

3. Bridging the Knowledge Gap

Another critical aspect of our solution is connecting expertise with those who need it. Through 2G communication technology, our In3ator can be monitored remotely, allowing experts to guide and support local healthcare workers. This feature is crucial in areas where specialized training is scarce, as it ensures that even novice users can operate and maintain the incubator effectively.

4. Enabling Real-Time Support and Collaboration

The built-in sensors in the In3ator provide real-time data, allowing our team to monitor performance and quickly address any issues. This not only ensures the incubator's reliability but also contributes to its longevity by enabling timely maintenance. The direct communication between healthcare workers and experts fosters a collaborative approach to problem-solving, improving the overall quality of care.

5. Expected Outcomes

With cost-effective manufacturing, localized production, and real-time support, we expect our solution to lead to several positive outcomes:

• Increased access to neonatal care in low-income areas.

• Improved reliability and durability of medical equipment.

• Enhanced training and support for healthcare workers.

• Reduced infant mortality rates through better neonatal care.

6. Evaluating Impact

To measure the success of our solution, we plan to track key metrics such as the number of In3ator deployed, their usage rates, and the frequency of successful interventions due to remote support. Additionally, we will monitor health outcomes, focusing on improvements in neonatal care and reductions in infant mortality rates.

By addressing the problem from multiple angles—cost, knowledge, and support—we believe our solution will have a significant and lasting impact on neonatal care in low-income regions, ultimately leading to improved health outcomes and saved lives.

Our impact goals for the In3ator solution focus on improving neonatal care and reducing infant mortality in low-income regions. Here's an outline of our key goals and how we measure our progress:

1. Expand Access to Neonatal Care

Our primary goal is to increase access to affordable, high-quality neonatal care equipment in areas with limited resources. To measure progress towards this goal, we track:

• The number of In3ator deployed in different regions.

• The geographic distribution of these devices, ensuring we reach remote and underserved areas.

2. Enhance Equipment Reliability and Durability

Another goal is to ensure that our in3ators are reliable and durable, reducing the need for frequent repairs or replacements. We measure this by:

• Monitoring the frequency and type of technical issues reported through our 2G communication system.

• Assessing the average lifespan of each device and comparing it to industry standards.

3. Provide Effective Training and Support

To improve neonatal care, we aim to equip healthcare workers with the knowledge and support they need to use our In3ator effectively. Our metrics for this goal include:

• The number of training sessions conducted for healthcare staff.

• Feedback from trainees on the usefulness of the training and their confidence in using the In3ator.

• The frequency of remote support interactions via our monitoring system.

4. Reduction in Infant Mortality Rates

Our ultimate goal: reduction in infant mortality rates in the regions we serve. This impact is more challenging to measure directly, but we monitor it by:

• Collecting data on infant mortality rates from local healthcare facilities before and after implementing our solution.

• Analyzing trends in neonatal health outcomes over time, seeking correlations with the deployment of our In3ators.

5. Foster Collaborative Partnerships

We aim to build strong partnerships with local hospitals, universities, and NGOs to support our mission. Our success in this area is measured by:

• The number of partnerships established with healthcare institutions and educational entities.

• The level of collaboration and engagement with these partners, including joint research, community outreach, and shared resources.

The core technology that powers In3ators is 2G communication, enabling real-time monitoring of the device's usage. This connectivity is crucial for bridging the gap between expertise and those who need it most, especially in developing countries where access to trained technicians and advanced technology is limited.

In many of these regions, a key challenge is the lack of personnel with the technical knowledge to operate and maintain complex medical devices like incubators. With In3ators's 2G-based system, we can monitor each device's status remotely, allowing experts to offer guidance and support to users, even if they are in remote or resource-limited areas.

This technology creates a direct link between healthcare professionals and expert support teams, facilitating troubleshooting and maintenance. It not only ensures that the In3ator is used correctly but also provides the necessary assistance to maintain it in good working condition. Through this innovative approach, In3ators acts as a bridge, connecting technical expertise with those in need, thereby improving healthcare outcomes in developing regions.

In addition to 2G connectivity, In3ator incorporates several other sophisticated technologies:

1. Temperature Regulation and Humidity Control: These features ensure that the critical parameters within the incubator are maintained, which is vital for the survival and health of neonates.
2. Phototherapy: This is used for treating neonatal jaundice, common in premature infants.
3. Forced Air Ventilation and Bed Inclination: These features help prevent respiratory issues and aid in comfortable positioning of the infants.

Moreover, In3ator is built with an open-source ethos. By making our blueprints publicly available, we encourage local innovation and adaptation. This approach allows engineers and healthcare professionals worldwide to contribute improvements and modifications that can be shared back with the community, enhancing the overall effectiveness and adaptability of the technology.

Case Study

A 28-year-old patient was followed up at the antenatal clinic for a monochorionic monoamniotic twin pregnancy with ventriculomegaly in one of the children with probable added hydrocephalus and intrauterine growth retardation. According to the last ultrasound carried out on 1/11/21 (D/M/Y), the gestational age was 25 weeks according to the ultrasound and 31 weeks according to the date of the last menstrual period. She arrived at Ebomé hospital on the evening of 31/10/21 with a diagnosis of severe pre-eclampsia (BP 200/110 mmHg) with associated vaginal bleeding. She was given a magnesium sulphate infusion and was prescribed absolute rest, in addition to the methyldopa she had previously been taking and dexamethasone according to the protocol for fetal lung maturation. She was monitored, and the babies began to develop fetal bradycardia on 2/11/21, so an emergency caesarean section was performed. 

Once the caesarean section had been performed and after initial resuscitation, the real chances of survival of both babies were assessed: palliative treatment was given priority to avoid suffering, as well as bereavement support for the family or active treatment, although the likelihood of survival was very low. Finally, the baby with a birth weight of 450g with the malformation detected by ultrasound died a few hours later. The other baby however, with a birth weight of 500g, is placed in the In3ator, adjusting the temperature and humidity according to his weeks of gestation. Oxygen therapy is continued and nutrition by nasogastric tube is started, with breast and artificial milk. The first week at a dose of 1ml every 2-3h of nutrition, with irregular progressive increase. At first it was dosed very slowly (1 ml per week) and then more rapidly, increasing by 1 ml every 2-3 days. Progressive weight gain, with several febrile episodes treated with Cefotaxime+Ampicillin+Gentamycin on several occasions, without microbiological isolation or apparent focus. Treatment with folic acid was also introduced. She has received a total of 4 blood transfusions (minimum Hb of 5.4 g/dl on 14/12/21).

Progressive improvement, oxygen therapy was withdrawn with good tolerance and the incubator was alternated with the kangaroo method, occasionally achieving direct breastfeeding from the last fortnight of December onwards. However, he continued to receive nasogastric tube feeding to ensure adequate nutrition. On 30/12/21 he weighed 1560g. On 4/01/22 his weight was 1745g and on 12/01/2022 he weighed 1937g. From the last week of December and the first week of January, the use of the incubator became more irregular, mainly due to the mother's wishes, as was much less necesssary. After removal of the nasogastric tube on 13/01/22 he was kept under observation for 5 more days, with no apparent complications, and finally discharged on 18/01/22 with a weight of 2070g.

Our solution team is composed entirely of part-time professionals. 

• NGO Integrants: 8 dedicated individuals who manage outreach, community relations, logistics. Plus extra student volunteers.

• Medical Council: 4 medical experts providing crucial guidance on health-related matters and compliance.

• Engineers: 4 engineers (industrial, biomedical, electronic engineers), responsible for the technical aspects of our solution.

• Legal and Finance Consultancy: Providing essential advice on legal compliance and financial strategies.

• Partnerships: Contracts with local hospitals and universities to foster collaboration, research, and development. Collaboration with Salesian Schools worldwide for manufacturing (Spain and Norway for the moment, but we are working on this expansion).

The journey of In3ator began in 2014 with the creation of the first prototype. In 2019, we established the NGO Medical Open World to provide a legal framework for the project, allowing us to scale our efforts and collaborate with a broader network of stakeholders. This formal structure has enabled us to advance our solution and expand our reach, ensuring that the In3ator meets high-quality standards and legal compliance.

Our team at In3ator is committed to fostering a diverse and inclusive work environment that reflects the global communities we aim to serve. We recognize that our mission to improve neonatal health outcomes can only be accomplished by embracing a variety of perspectives and expertise. Here’s how we ensure our team is diverse, reduces barriers to opportunity, and creates an inclusive environment:

1. Diversity in Hiring: We strive to maintain a multicultural team, with members coming from a range of geographic, ethnic, and academic backgrounds. Our leadership team includes professionals from fields such as pediatric healthcare, biomedical engineering, and public health policy, reflecting gender diversity and multidisciplinary expertise. We actively recruit individuals from countries that heavily utilize In3ator, ensuring that our team has firsthand understanding of the challenges faced by those in under-resourced areas. As such. we heavily encourage teamwork and cross-functional collaboration to break down silos and foster a sense of community.

1. Inclusive Policies and Practices: We have implemented policies that promote a culture of inclusion and respect. This includes mandatory training on cultural competency and unconscious bias for all employees. Our flexible working conditions accommodate different personal and cultural needs, which is crucial for our globally distributed team.

2. Barriers to Opportunity: We actively work to minimize barriers to opportunity through initiatives such as internships and training programs with local universities in the regions we serve. These programs are designed to uplift individuals from underrepresented groups by providing them with professional development opportunities and pathways into the healthcare technology sector.

Our business model is designed to be sustainable, scalable, and impactful, focusing on providing affordable medical equipment to low-income regions while ensuring a reliable revenue stream. Here's an outline of our business model's key components:

1. Cost-Effective Manufacturing and Distribution

We partner with Salesian schools worldwide to manufacture our In3ators at low cost. This collaboration allows us to leverage existing infrastructure and skilled labor, significantly reducing production expenses. By manufacturing locally in different regions, we cut down on shipping and logistics costs, making our distribution network more efficient and cost-effective.

2. Affordable Pricing Strategy

Our pricing strategy is designed to ensure that our In3ators are accessible to low-income clients and healthcare facilities. We aim to keep prices low enough to encourage widespread adoption while maintaining a margin that sustains our operations. This approach allows us to reach a broader market, driving impact while ensuring financial stability.

3. Revenue Streams

Our primary revenue stream comes from the sale of In3ators to healthcare facilities, NGOs, and government agencies in developing regions. We also offer ongoing maintenance and support services, generating additional revenue through service contracts. These service agreements ensure that our devices remain operational and provide value to our clients over the long term.

4. Partnerships and Grants

In addition to direct sales, we actively seek partnerships with other organizations, such as NGOs, universities, and government agencies. These partnerships often include grants or funding to support specific projects or research initiatives. This additional funding helps us expand our reach and develop new features or products, enhancing our business model's sustainability.

5. Community Engagement and Social Impact

Our business model includes a strong focus on community engagement and social impact. By partnering with local hospitals and universities, we create opportunities for collaboration and knowledge exchange, fostering a sense of community ownership. This approach not only improves the adoption and use of our products but also helps us build a positive reputation, contributing to our brand's growth and sustainability.

6. Monitoring and Continuous Improvement

To ensure the long-term success of our business model, we use a robust monitoring system to track the performance of our In3ators in the field. This data-driven approach allows us to identify areas for improvement and adapt our business strategy as needed. It also provides evidence of our impact, which we use to attract additional partnerships and funding.

Altogether, these characteristic components of the In3ator give it value and holistically solve the overarching problem of lack of high newborn mortality by addressing 3 key aspects: newborn incubators, access to training and limited connectivity. In terms of Global Surgery, it addresses another three pillars: Research, Education and Advocacy. 

Our financial sustainability plan revolves around innovative partnerships and cost-effective manufacturing. Given our focus on low-income clients, we aim to keep costs minimal while maintaining high-quality production and distribution. Here's how we achieve this and evidence of its success:

1. Collaboration with Salesian Schools

Our strategic partnership with Salesian schools is central to our business model. These schools have a global presence and are committed to supporting community development. By working closely with them, we gain access to a network of skilled students and teachers who contribute to the manufacturing process at no cost. This collaborative approach significantly reduces our production expenses.

2. Localized Manufacturing

To further lower costs, we aim to manufacture our In3ators locally in each country. This approach minimizes shipping and logistics expenses, reducing our carbon footprint and ensuring that each unit reaches its destination efficiently. By setting up production facilities within local Salesian schools, we leverage existing infrastructure and expertise, cutting down on the need for extensive new resources.

3. Cost-Effective Logistics

Since our manufacturing process is distributed across different regions, we can streamline logistics by reducing the distance between production and delivery points. This reduces shipping costs and improves delivery times, which is crucial for maintaining customer satisfaction and supporting healthcare initiatives in low-income areas.

4. Building a Sustainable Business Model

The reduced manufacturing and logistics costs allow us to offer our products at a price point that is accessible to our target market. This affordability is essential for reaching low-income clients who need our products the most. By keeping prices low, we can increase our market penetration and build a sustainable customer base. Also, we are working on a local customer service to provide maintenance and create local employment.

Evidence of Success

• Increased Production Volume: Since implementing our partnership with Salesian schools, we've been able to increase the production volume of in3ators, meeting the demand from various countries.
• Wider Geographic Reach: By manufacturing locally, we've expanded our reach to more regions, allowing us to support healthcare initiatives in areas where traditional manufacturing and logistics would be cost-prohibitive.
• Positive Community Impact: Our collaboration with Salesian schools has had a positive impact on local communities by providing students with valuable skills and contributing to community development.